SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

AIM ImmunoTech Inc.
Date: July 24, 2025 · CIK: 0000946644 · Accession: 0001493152-25-011378

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-284443

Date
July 28, 2025
Author
Maxim Group LLC
Form
CORRESP
Company
AIM ImmunoTech Inc.

Letter

Re: AIM ImmunoTech Inc.

July 24, 2025

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549-1004

Registration Statement on Form S-1, as amended

File No. 333-284443

Ladies and Gentlemen:

As the placement agent of the proposed offering of AIM ImmunoTech Inc. (the "Company"), we hereby join the Company's request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 5:00 p.m., Eastern Time, on Monday, July 28, 2025, or as soon thereafter as is practicable.

Pursuant to Rule 460 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that, through July 24, 2025, we distributed to each dealer, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies, as well as "E-red" copies of the Preliminary Prospectus dated July 22, 2025, as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

Very truly yours,
Maxim Group LLC

Show Raw Text
CORRESP
 1
 filename1.htm

 July
24, 2025

 VIA
EDGAR

 U.S.
Securities and Exchange Commission

 Division
of Corporation Finance

 100
F Street, N.E.

 Washington,
D.C. 20549-1004

 Re:
 AIM ImmunoTech Inc.

 Registration Statement on Form S-1, as amended

 File No. 333-284443

 Ladies
and Gentlemen:

 As
the placement agent of the proposed offering of AIM ImmunoTech Inc. (the "Company"),
we hereby join the Company's request for acceleration of the above-referenced Registration Statement, requesting effectiveness
for 5:00 p.m., Eastern Time, on Monday, July 28, 2025, or as soon thereafter as is practicable.

 Pursuant
to Rule 460 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as
amended, we wish to advise you that, through July 24, 2025, we distributed to each dealer, who is reasonably anticipated to be invited
to participate in the distribution of the security, as many copies, as well as "E-red" copies of the Preliminary Prospectus
dated July 22, 2025, as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

 The
undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as
amended.

 Very truly yours,

 Maxim Group LLC

 By:

 /s/
 Ritesh Veera

 Name:
 Ritesh
 Veera

 Title:
 Co-Head
 of Investment Banking